Amyloid β-protein (Aβ) is central to the pathology of Alzheimer's disease. Of the two predominant Aβ alloforms, Aβ 1-40 and Aβ 1-42 , the latter forms more toxic oligomers. C-terminal fragments (CTFs) of Aβ were recently shown to inhibit Aβ 1-42 toxicity in vitro. Here, we studied Aβ 1-42 assembly in the presence of three effective CTF inhibitors and an ineffective fragment, Aβ 21-30 . Using a discrete molecular dynamics approach that recently was shown to capture key differences between Aβ 1-40 and Aβ 1-42 oligomerization, we compared Aβ 1-42 oligomer formation in the absence and presence of CTFs or Aβ 21-30 and identified structural elements of Aβ 1-42 that correlated with Aβ 1-42 toxicity. CTFs co-assembled with Aβ 1-42 into large heterooligomers containing multiple Aβ 1-42 and inhibitor fragments. In contrast, Aβ 21-30 co-assembled with Aβ 1-42 into heterooligomers containing mostly a single Aβ 1-42 and multiple Aβ 21-30 fragments. The CTFs, but not Aβ 21-30 , decreased the β-strand propensity of Aβ 1-42 in a concentration-dependent manner. CTFs and Aβ 21-30 had a high binding propensity to the hydrophobic regions of Aβ 1-42 , but only CTFs were found to bind the Aβ 1-42 region A2-F4. Consequently, only CTFs but not Aβ 21-30 reduced the solvent accessibility of Aβ 1-42 in region D1-R5. The reduced solvent accessibility of Aβ 1-42 in the presence of CTFs was comparable to the solvent accessibility of Aβ 1-40 oligomers formed in the absence of Aβ fragments. These findings suggest that region D1-R5, which was more exposed to the solvent in Aβ 1-42 than in Aβ 1-40 oligomers, is involved in mediating Aβ 1-42 oligomer neurotoxicity.
Introduction
Alzheimer's disease (AD) is an irreversible, progressive neurodegenerative disorder that is the dominant cause of dementia in the elderly. One of the hallmarks of AD is accumulation of extracellular senile plaques, which contain fibrillar aggregates of amyloid β-protein (Aβ). Genetic, pathologic, and biochemical evidence strongly supports the hypothesis that low-order oligomeric assemblies of Aβ, rather than fibrils, are the proximate neurotoxic agents in AD. [1] [2] [3] [4] [5] [6] [7] The majority of Aβ oligomers were found to be neurotoxic, 8 and certain oligomers decreased neuronal viability 10-to 100-fold more strongly than Aβ fibrils. 9 Aβ 1-40 and Aβ , the major Aβ alloforms in the brain, differ by the presence of two amino acids, I41 and A42, at the C-terminus of the latter. Aβ aggregates faster, 10, 11 forms more toxic assemblies, 5 and is genetically linked to aggressive, early-onset familial forms of AD. 12 Cross-linking studies showed that Aβ forms pentamers and hexamers (paranuclei) and multiples of paranuclei, including dodecamers and octadecamers, whereas Aβ 1-40 exists as a mixture of monomers through tetramers. 13 These observations have been confirmed independently by ion-mobility spectrometry/mass spectrometry. 14, 15 Interestingly, Aβ dodecamers, which putatively form by selfassociation of two paranuclei, have been detected in vivo in several independent studies. [16] [17] [18] [19] In recent years, an ab initio discrete molecular dynamics (DMD) approach 20 using a four-bead protein model and residue-specific hydropathic interactions offered important insights into the folding and assembly of Aβ and Aβ . [21] [22] [23] [24] [25] This approach recapitulated the essential, experimentally observed differences between the folding and oligomerization of Aβ and Aβ and demonstrated that Aβ 1-42 but not Aβ 1-40 oligomerization was driven primarily through intermolecular interactions involving the C-terminal region (I31-A42). 22, 23, 25 The DMD approach also predicted a quasi-stable turn at the C-terminus of Aβ , which does not occur in Aβ , 22 a prediction that was supported by several experimental studies. [26] [27] [28] [29] [30] In a most recent study, Streltsov et al. reported the first X-ray structure of the Aβ 18-41 tetramer encapsulated in a shark Ig new antigen receptor, which resembles the DMD-derived oligomeric structures. 31 The DMD findings have led to a hypothesis that C-terminal fragments (CTFs) of Aβ 1-42 may interfere with Aβ 1-42 oligomerization. Recently, we reported that Aβ CTFs ranging from Aβ [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] to Aβ [39] [40] [41] [42] , as well as Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , attenuated Aβ 1-42 neurotoxicity in neuronal cell culture. 32, 33 We also investigated the aqueous solubility, aggregation kinetics, and morphology of CTFs 33 and found that their aggregation propensity correlated with the previously reported 34 tendency to form β-hairpin structures, whereas their ability to inhibit Aβ 1-42 -induced neurotoxicity correlated with a tendency to form an irregular "coil-turn" structure. 33 Dynamic light-scattering (DLS) data revealed that two Aβ 1-42 oligomer populations, which were scarcely populated in the absence of inhibitors, were enhanced by CTFs in an inhibitor-specific manner. In particular, stabilization of the smaller of the two Aβ 1-42 /CTF heterotypic assembly populations with a hydrodynamic radius of 8-12 nm correlated with the degree of toxicity inhibition. 35 Stabilization of nontoxic Aβ 1-42 assemblies might thus be a promising strategy for designing Aβ 1-42 toxicity inhibitors. 35 A similar mechanism was found for several other inhibitors, including scyllo-inositol [36] [37] [38] benzothiazole derivatives, 39 and the polyphenols epigallocatechin-3-gallate, 40, 41 resveratrol, 42 myricetin, and nordihydroguaiaretic acid. 39 However, the mode of interaction of inhibitors with Aβ 1-42 and the structural changes in Aβ 1-42 that are required for a successful toxicity inhibition are unknown.
Our preliminary DMD study of Aβ 1-42 assembly in the presence of Aβ [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , or Aβ [39] [40] [41] [42] , using Aβ 1-42 /CTF molar concentration ratios of up to 1:2, demonstrated that these CTFs inserted themselves among Aβ 1-42 peptides, reducing their intermolecular contacts. 32 Inhibition of Aβ 1-42 toxicity by CTFs in a cell culture was concentration dependent and most efficient at the Aβ 1-42 /CTF molar concentration ratio of ∼ 1:10. Here, we applied the DMD approach to examine the assembly of Aβ in the presence of three CTFs that efficiently inhibited Aβ 1-42 toxicity and a control peptide, Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , which had no effect on Aβ 1-42 toxicity, 33 at several Aβ 1-42 /Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] concentration ratios, including 1:10. We explored the effects of Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , Aβ [39] [40] [41] [42] , and two additional Aβ fragments (Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ) that were not included into our prior DMD study 32 using an improved, recently reported parametrization of the DMD approach. 24, 25 The aim of the present work was to explore structural elements involved in Aβ 1-42 toxicity inhibition by CTFs. To achieve that, we analyzed the Aβ 1-42 structures formed in the presence of effective inhibitors and compared them to Aβ oligomers formed in the absence of inhibitors and in the presence of ineffective Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] fragments. We also compared the Aβ assembly structures formed in the presence of Aβ fragments to Aβ 1-40 oligomer populations (formed in the absence of Aβ fragments). Based on the present computational results and previously reported toxicity data, 32, 33 we propose a mechanism in which CTFs inhibit Aβ toxicity by binding to specific regions of Aβ , reducing its ability to form a β structure, and interrupting putative interactions of Aβ 1-42 with its cellular targets.
Results
We selected four Aβ X-Y fragments to study their effect on Aβ assembly. Of all the experimentally examined CTFs, 33 Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] was chosen because it was the strongest inhibitor of neurotoxicity. 32, 33 Aβ [39] [40] [41] [42] , the shortest of all the CTFs under study, showed surprisingly high inhibition of neurotoxicity. 32 Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] was selected because its degree of Aβ 1-42 toxicity inhibition was comparable to that of the other two CTFs, 33 and Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , which did not inhibit Aβ 1-42 toxicity in cell culture, was chosen as a control peptide.
We simulated Aβ 1-42 assembly in the presence of CTFs or Aβ 21-30 using a four-bead protein model with backbone hydrogen bonding and amino-acidspecific interactions, as described in Methods (see Supplementary Methods in Supplementary Material). We used the implicit solvent parameters E HP = 0.3 and E CH = 0 and physiological temperature estimate T = 0.13, which recently has been shown to match well the in vitro temperature dependence of the average β-strand in Aβ 1-40 and Aβ 1-42 monomers 24 and the distinct oligomer size distributions of Aβ 1-40 , Aβ 1-42 , and their Arctic mutants, [E22G] Aβ 1-40 and [E22G]Aβ 1-40. 25 The total number of Aβ 1-42 and fragment peptides and simulation box sizes (Table I in Supplementary Material) were chosen to correspond to a total molar concentration of ∼3-4 mM as used in the previous DMD studies. 22, 25 Typical molar concentrations in in vitro studies are 10-to 100-fold lower than the total molar concentration in our computational study. Due to limitations in the total number of atoms and timescales that can currently be efficiently studied by computer simulations, 43 millimolar concentrations are required for proteins to interact with each other and thus form assemblies and to obtain sufficient statistics on the assembled structures. The effect of Aβ fragments on Aβ 1-42 assembly and the resulting structures were quantified and compared to unaltered Aβ 1-42 oligomer structures using data from the recently published work. 25 In the description of our results below, the following abbreviations for specific Aβ regions are used: CHC, central hydrophobic cluster (L17-A21); MHR, mid-hydrophobic cluster (I31-M35); and CTR, C-terminal region (V39-A42).
Aβ X-Y and Aβ 1-42 associate into Aβ 1-42 /Aβ X-Y heterooligomers Initially separated monomeric Aβ 1-42 and toxicity inhibitor Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , or Aβ [39] [40] [41] [42] (Fig. 1a ) associated first into small Aβ 1-42 /CTF heterooligomers of various sizes and compositions ( Fig. 1b ) and then into larger heterotypic assemblies (Fig. 1c) , and finally, all Aβ 1-42 and CTF peptides in each trajectory converged into a single large heterotypic assembly ( Fig. 1d-e ). These results are in qualitative agreement with the DLS observations of increased abundance of Aβ 1-42 oligomers in the presence of these CTFs relative to Aβ 1-42 alone. 35 Thus, the three toxicity inhibitors (Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , or Aβ 39-42 ) acted as a "glue" capturing Aβ 1-42 molecules into an amorphous heterotypic assembly. In contrast, the control peptide Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] had the opposite effect. In the presence of this fragment, both Aβ 1-42 and Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] remained predominantly monomeric. In addition, small heterotypic assemblies comprising an Aβ 1-42 molecule surrounded by seven to eight Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] peptides also were observed ( Fig. 2a -e, see also Fig. II in Supplementary Material). The size distributions of Aβ 1-42 /Aβ X-Y assemblies ( Fig. II in Supplementary Material) evolved within 5× 10 6 to 10 × 10 6 simulation steps into a quasi-steady state, after which the temporal changes in the oligomer size distributions were no longer statistically significant up to 20 × 10 6 simulation steps.
CTFs inhibit β-strand formation in Aβ The structural basis for Aβ 1-42 neurotoxicity is as yet unknown. Several studies addressed the relevance of β-strand formation in Aβ-oligomermediated toxicity. Neurotoxic pre-fibrillar Aβ assemblies lacking the cross-β structure (which is characteristic of Aβ fibrils with ∼45-55% of β-sheet structure) were identified by several studies. 13, 19, 45, 46 In contrast, Chimon et al. described neurotoxic Aβ intermediates with parallel β-sheet structures, 47 and Wu et al. found fibrillar oligomers that nucleated formation of toxic oligomers but did not form fibrils. 48 Our DMD-derived oligomer structures 25 are consistent with in vitro data by Kirkitadze et al. who found Aβ 1-40 and Aβ 1-42 oligomers with a relatively low β-strand of 10-20% 45 and no cross-β structure. Here, we asked whether changes in the β-strand propensity in Aβ 1-42 due to the presence of CTFs and Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] at the stage of initial hydrophobic collapse may correlate with their reported ability to inhibit Aβ 1-42 toxicity.
To examine the effect of Aβ fragments on β-strand formation in Aβ 1-42 , we calculated the average β-strand content, 〈β-strand〉, of Aβ 1-42 within Aβ 1-42 /Aβ X-Y assemblies and compared them to 〈β-strand〉 in Aβ 1-42 oligomers formed in the absence of fragments ( Fig. 3a , continuous curves). 〈β-Strand〉 in Aβ 1-42 decreased from 19% in the absence of fragments to ∼16% at relative molar concentrations of Aβ X-Y of ∼0.5 for all toxicity inhibitors. At the relative Aβ X-Y molar concentrations of ∼1, Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] further reduced 〈β-strand〉 in Aβ 1-42 to ∼15%. At this Aβ 31-42 concentration, 〈β-strand〉 in Aβ 1-42 was at its lowest value, and at the relative Aβ 31-42 molar concentration above 2 and up to 10, 〈β-strand〉 remained at a value of ∼16% (∼16% reduction). 〈β-Strand〉 in Aβ 1-42 above the relative Aβ 30-40 molar concentration of ∼2 decreased with the Aβ 30-40 concentration and reached a value of ∼12% at the relative molar concentration of 10 (37% reduction). Thus, of the two longer toxicity inhibitors, Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] was significantly more efficient in suppressing the formation of β-strand structure in Aβ 1-42 than Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . The shortest toxicity inhibitor, Aβ [39] [40] [41] [42] , had the most prominent effect on 〈β-strand〉 in Aβ 1-42 at all relative molar concentrations N 0.5 and reduced 〈β-strand〉 to ∼10% (48% reduction). In contrast to the three toxicity inhibitors, the control peptide Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] increased 〈β-strand〉 in Aβ (Fig.  3a , gray continuous curve), and this increase was strongly Aβ 21-30 concentration dependent.
〈β-Strand〉 propensity in the Aβ fragments themselves was variable. All three toxicity inhibitors showed similar concentration dependencies of 〈β-strand〉 ( Fig. 3a , black, red, and green broken curves), experiencing a slight Aβ 1-42 -induced increase in 〈β-strand〉 about or just below the relative molar CTF concentrations of 0.5, followed by a decrease at higher CTF concentrations. Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] had the highest 〈β-strand〉 values at all concentrations under study, reaching ∼12% at the highest relative Aβ 31-42 molar concentration of 10, followed by Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] with ∼7% and Aβ [39] [40] [41] [42] with ∼2%. The control peptide Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] was characterized by the highest 〈β-strand〉 (ranging from 12.8% at the lowest to 17.6% at the highest Aβ 21-30 concentration) of all four Aβ fragments. 〈β-Strand〉 in Aβ fragments was at all concentrations lower than 〈β-strand〉 in Aβ oligomers formed in the absence of fragments (19.1%) and significantly lower than that of Aβ 1-42 assembling in the presence of Aβ 21-30 at the 1:10 molar concentration ratio (27.9%). As shown in Fig. 3b , the β-strand propensity of Aβ fragments correlated with the average β-strand in Aβ 1-42 and also with the Aβ-fragment-induced change in the Aβ 1-42 β-strand propensity. To our knowledge, there are currently no experimental data on the effect of Aβ fragments on the secondary structure of Aβ 1-42 ; thus, direct comparison between in silico and in vitro data cannot be made. Nonetheless, our analysis suggests that the Aβ 1-42 secondary structure changes may be relevant to the Aβ-fragment-induced changes in Aβ 1-42 toxicity.
In addition, we compared β-strand propensities per residue in Aβ 1-40 and Aβ 1-42 hexamers formed in the absence of fragments (Fig. 3c , blue and orange curves) with the β-strand propensities per residue in heterotypic assemblies comprising Aβ 1-42 and Aβ fragments ( Fig. 3c , black, red, green, and gray curves). None of the three toxicity inhibitors changed the relative distribution of β-strand propensities along the Aβ 1-42 sequence. The β-strand propensity per residue in Aβ 1-42 hexamers was significantly different from the one found in Aβ 1-40 hexamers, as reported and discussed in our prior work. 25 For example, region A2-F4 in Aβ 1-40 but not in Aβ 1-42 hexamers had a high β-strand propensity (Fig. 3c , blue and orange curves). All three toxicity inhibitors reduced the β-strand propensities in region Q15-L17 of Aβ 1-42 , but only Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and Aβ [39] [40] [41] [42] reduced these propensities at R5-V12, A21-S26, and I31-V36. The control peptide Aβ 21-30 , on the other hand, substantially increased the β-strand propensity in several Aβ 1-42 regions: D7-E11, F19-F20, E22-V24, G29-I32, and L34-V36 ( Fig. 3c , gray curve).
Aβ X-Y fragments alter the tertiary and quaternary structures of Aβ Here, we quantified structural changes in Aβ due to the presence of each fragment and identified the specific peptide regions involved in the interaction between Aβ 1-42 and Aβ X-Y . For this purpose, simulation data corresponding to the Aβ 1-42 /Aβ X-Y molar concentration ratio 1:10, which was needed for an efficient toxicity inhibition, were used ‡. 32 In these simulations, six Aβ 1-42 molecules co-assembled with 229 Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , 210 Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , 630 Aβ [39] [40] [41] [42] , or 252 Aβ 21-30 peptides using a simulation box size of 318 Å.
Effect of Aβ fragments on the tertiary structure of Aβ The tertiary structures of Aβ 1-42 in the absence or presence of Aβ fragments are shown in Fig. 4a -e. All three toxicity inhibitors slightly reduced the number and strength of intramolecular contacts relative to Aβ 1-42 hexamers formed in the absence of inhibitors, mostly in the N-terminal region ( Fig. 4a -e, box 1). Almost no change in the tertiary structure was observed at the C-terminal region ( Fig. 4a -e, box 4). Among the three inhibitors, Aβ 39-42 reduced the intramolecular contacts in Aβ 1-42 the most (Fig. 4d ). The control peptide Aβ 21-30 inhibited the Aβ 1-42 intramolecular contacts at the N-terminal region ( Fig. 4e , box 1) but, at the same time, increased the number and strengths of intramolecular contacts in all other regions of Aβ 1-42 ( Fig. 4e , boxes 2-5) relative to Aβ 1-42 hexamers (Fig. 4a ). Overall, the three CTFs decreased-whereas Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] increasedthe stability of the Aβ 1-42 tertiary structure. The exception was the N-terminal region ( Fig. 4a -e, box 1), where all Aβ X-Y reduced intramolecular contacts in Aβ .
Effect of Aβ fragments on the quaternary structure of Aβ The quaternary structures of Aβ 1-42 in the absence or presence of Aβ fragments are shown in Fig. 4f -j. All four Aβ fragments reduced both the number and the strengths of intermolecular contacts among Aβ 1-42 molecules in a concentration-dependent way ( Fig. IV, Supplementary Material) . The remaining intermolecular Aβ 1-42 contacts were Aβ X-Y specific. An almost complete absence of specific intermolecular contacts among Aβ 1-42 was observed in the presence of Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . The interpretation of this reduction was, however, different for the two peptides. In the case of Aβ 21-30 , Aβ 1-42 molecules did not interact because they belonged to different heterotypic assemblies, whereas in the case of Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , all six Aβ molecules belonged to the same Aβ 1-42 /Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] heterooligomer but were spatially separated from each other, resulting in the reduction in all intermolecular contacts. Similar to Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] and Aβ 39-42 spatially separated individual Aβ 1-42 molecules within heterooligomers. Interestingly, none of the four fragments completely inhibited the intermolecular Aβ 1-42 contacts. In the presence of Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] or Aβ [39] [40] [41] [42] , the intermolecular contacts among Aβ 1-42 molecules were more abundant than in the presence of Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] . In the presence of Aβ [39] [40] [41] [42] , the intermolecular contacts among the CHC, MHR, and CTR regions of Aβ 1-42 were more abundant than in the presence of Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . Aβ 31-42 induced a few new intermolecular contacts involving the N-terminal region G9-V12 of Aβ 1-42 ( Fig. 4h , box 5).
Interaction regions between Aβ 1-42 and Aβ fragments
Intermolecular contacts between Aβ 1-42 and each fragment are shown in Fig. 4k -n. Boxes 1-4 indicate the regions of Aβ 1-42 that most strongly interacted with all four fragments: the A2-F4 region, CHC, MHR, and CTR. Of the four fragments, Aβ [39] [40] [41] [42] formed the most frequent contacts with Aβ 1-42 , likely due to its highly hydrophobic nature and its short length ( Fig. 4m ). Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and Aβ 31-42 displayed comparable average numbers and strengths of intermolecular contacts ( Fig. 4k and l), though the strengths were slightly increased in Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] relative to Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . The intermolecular contacts between the control Aβ 21-30 peptide and Aβ 1-42 were comparable to those observed for Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] in CHC, MHR, and CTR ( Fig. 4n , boxes 2-4). There were no contacts between Aβ 21-30 and the A2-F4 region of Aβ 1-42 ( Fig. 4n , box 1). Instead, region R5-V12 of Aβ formed an antiparallel β-sheet with Aβ 21-30 ( Fig. 4n , region between boxes 1 and 2). These contacts were specific to Aβ 21-30 interaction with Aβ 1-42 and were not observed for any other Aβ fragment. Thus, the interaction between Aβ 21-30 and Aβ 1-42 was stronger than would have been expected based on the strongly hydrophilic nature of Aβ 21-30 relative to CTFs.
Binding propensity of Aβ X-Y to Aβ 1-42
To quantify the degree of the interaction between Aβ 1-42 and Aβ X-Y , we calculated the binding propensity by averaging the intermolecular Aβ 1-42 / Aβ X-Y contact maps shown in Fig. 4k -n over the specified regions. The results are shown in Table 1 . For comparison, the binding propensity of Aβ 1-42 to itself in hexamers was included. We found that Aβ [39] [40] [41] [42] had ∼2to 4-fold higher binding propensity than the other three fragments to the four regions of Aβ 1-42 under study (Table 1 ). Aβ 21-30 had a binding propensity ‡ A similar structural analysis for Aβ and Aβ fragments using simulation data obtained at the four lower Aβ 1-42 /Aβ X-Y concentration ratios is described in Supplementary Results in Supplementary Material (Figs. III-VII). similar to that of CHC, MHR, and CTR as Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and Aβ 31-42 despite its predominant hydrophilic nature. Importantly, Aβ 21-30 had at least 5-fold lower binding propensity to the A2-F4 region of Aβ 1-42 relative to the CTFs, highlighting a possible relevance of the A2-F4 region of Aβ 1-42 in mediating toxicity. . Intramolecular (a-e) and intermolecular (f-j) contact maps of Aβ 1-42 assemblies formed in the absence and at 1:10 molar concentration ratio of the three toxicity inhibitors (Aβ 30-40 , Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , and Aβ [39] [40] [41] [42] ) and the control peptide Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . The intramolecular and intermolecular contact maps of Aβ 1-42 hexamers are shown in (a) and (f), respectively. The intermolecular maps that elucidate regions of contact between Aβ 1-42 and each of the four Aβ fragments are shown in (k) to (n). The contact maps are oriented such that the average number of contacts among the N-terminal amino acids is displayed at the top left corner and the average number of contacts among the C-terminal amino acids is at the bottom right corner. The boxes mark regions of concentrated contacts.
CTFs reduce solvent exposure of the N-terminal region of Aβ 1-42
Aβ 1-42 oligomers presumably mediate neurotoxicity through interaction with cell membranes and/ or other cellular components. [49] [50] [51] [52] Important insights into the specific Aβ 1-42 regions participating in these interactions may be gleaned from studying which regions are most exposed to the environment within homotypic and heterotypic assemblies. In our recent study, we showed that the solventaccessible surface area (SASA) in the N-terminal region was significantly lower in Aβ 1-40 hexamers than in Aβ 1-42 hexamers (see Fig. S5b in Supporting Information of Ref. 25) . To check whether this difference between Aβ 1-40 and Aβ 1-42 was specific to hexamers or a more general feature, we used here data from our previous study 25 to calculate SASA per residue using the entire Aβ 1-40 and Aβ 1-42 populations of monomers and oligomers. The results demonstrated that the distinct SASA profiles in the N-terminal region D1-R5 between Aβ 1-40 and Aβ 1-42 were characteristic not only for hexamers but also for entire Aβ 1-40 and Aβ 1-42 populations (Fig. 5 , blue and orange curves). The regions of Aβ that on average were most exposed to the solvent were mostly hydrophilic residues (D1, R5-S8, H13-Q15, E22-D23, and S26-K28), whereas the hydrophobic regions (CHC, MHR, and CTR) had low SASA values.
To quantify the effect of Aβ fragments on the solvent exposure of Aβ 1-42 , we calculated SASA per residue using the simulation data acquired at the Aβ 1-42 /Aβ X-Y molar concentration ratio 1:10 ( Fig. 5 ). For Aβ 1-42 assembled in the presence of the three toxicity inhibitors, the SASA in region D1-R5 was reduced relative to Aβ 1-42 assembled in the absence of inhibitors. For all three CTFs, the SASA values almost overlapped with the SASA values derived for Aβ assemblies formed in the absence of Aβ fragments (Fig. 5 ). In contrast, Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] induced an increased SASA in region D1-R5 of Aβ 1-42 ( Fig. 5 , gray curve). The observed correlation between solvent exposure of the N-terminal region of Aβ and the degree of toxicity suggests that the Nterminal region D1-R5 of Aβ 1-42 is involved in Aβ 1-42 -mediated toxicity, likely through interaction with cellular targets.
Discussion
Our recent in vitro studies of a series of CTFs (Aβ X-42 , X = 29-39; Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] ) and the control peptide Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] were studied for aqueous solubility, aggregation propensity, and morphology [39] [40] [41] [42] binding propensities that were two to four times larger than those for any other fragment. c Aβ 21-30 binding propensity to the A2-F4 region more than five times lower than that for any other fragment. The error bars correspond to standard error of the mean. characteristics. None of these properties directly correlated with the ability of CTFs to inhibit toxicity. 33 Rather, the degree of toxicity inhibition by CTFs, in particular, Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , Aβ [39] [40] [41] [42] , and Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , correlated with stabilization of the smaller and attenuation of the larger of the two oligomer populations with hydrodynamic radii of 8-12 nm and 20-60 nm, respectively, as measured by DLS. 35 These findings are difficult to reconcile using a simple explanation of how the inhibitors affect Aβ 1-42 assembly but, rather, demonstrate that (i) CTFs do not prevent Aβ 1-42 self-assembly, (ii) CTFs bind to Aβ 1-42 and subtly affect its assembly, and (iii) CTFs and Aβ 1-42 co-assemble into oligomeric structures that are not grossly different from those formed in the absence of inhibitors (i.e., they have similar hydrodynamic radii 35 and similar morphologies) (H.L. and G.B., unpublished results).
Two plausible mechanisms by which inhibitors could reduce Aβ 1-42 toxicity are as follows: (a) CTFs modulate Aβ 1-42 oligomer structure by inducing subtle structural changes or (b) CTFs mask Aβ 1-42 groups or regions that interact with cellular targets. These mechanisms are not mutually exclusive and may be operating together. Our purpose in the present study was to gain insight into these mechanisms from the relatively high resolution data provided by the DMD approach. Thus, we examined the structures and structural changes occurring during early stages of Aβ assembly in the presence of three selected toxicity inhibitors (Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] , Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , and Aβ [39] [40] [41] [42] ) or a control peptide (Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ). Aβ 1-42 was found to co-assemble with all three CTFs under study into large heterooligomers. In contrast, Aβ 1-42 and Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] formed small heterotypic assemblies comprising mostly one Aβ 1-42 and seven to eight Aβ 21-30 peptides. Thus, in our simulations, toxicity inhibitors but not control peptides induced formation of large heterooligomers.
Mechanisms by which toxicity inhibitors interact with Aβ to reduce toxicity are not well understood. Liu et al. showed that a simple disaccharide, trelahose, inhibited oligomer formation and reduced toxicity of Aβ 1-40 but not that of Aβ 1-42. 53 This study suggests that trelahose induced alloform-specific structural changes that disrupted specific interactions of Aβ 1-40 , but not those of Aβ 1-42 , with its environment. Similarly, here, we found specific interactions of different inhibitors with Aβ 1-42 . Though all three CTFs decreased the tendency of Aβ 1-42 to form β-strands, Aβ [39] [40] [41] [42] was the most efficient and Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , the least efficient among the three. The ability to disrupt β-strand formation was negatively correlated with the β-strand content in CTFs themselves. In contrast to CTFs, Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] significantly increased the propensity of Aβ 1-42 to form the β-strands.
Of the four Aβ fragments, Aβ [39] [40] [41] [42] interacted most strongly with Aβ 1-42 . Interestingly, the predominantly hydrophilic Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] interacted with Aβ 1-42 as strongly as Aβ [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] or Aβ [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] , though the location and nature of these interactions were distinct from those between Aβ 1-42 and the two CTFs. These results suggest that peptide length affects the Aβ 1-42 /Aβ X-Y interaction more than does its hydrophobic versus hydrophilic nature. As expected, the self-assembly of Aβ X-Y was strongly affected by the hydrophobic versus hydrophilic character of the fragments. In contrast to the CTFs, Aβ 21-30 did not self-assemble. Importantly, unlike the three toxicity inhibitors, Aβ 21-30 did not interact with the A2-F4 region of Aβ .
An involvement of the A2-F4 region in Aβ 1-40 but not Aβ folding and oligomer formation was demonstrated in previous DMD studies. 22, 24, 25 In Aβ 1-40 , the A2-F4 region had a relatively high βstrand propensity, 22, 24, 25 resulting in less favorable Aβ 1-40 hexamer formation, which included a slow dock-and-lock intermolecular interaction involving the A2-F4 β strand regions. 25 Intermolecular contacts among the A2-F4 regions caused the Nterminal region to be more shielded from the solvent in Aβ 1-40 than in Aβ 1-42 oligomers.
Similar to the differences between Aβ 1-40 and Aβ 1-42 , our present analysis showed that region D1-R5 of Aβ 1-42 was significantly less exposed to the solvent in heterooligomers formed in the presence of toxicity inhibitors than in Aβ 1-42 oligomers formed in the absence of Aβ fragments. In contrast, in the presence of Aβ [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] , the solvent exposure of the Nterminal region D1-R5 of Aβ 1-42 significantly increased relative to unaltered Aβ 1-42 oligomers.
Our hypothesis that the N-terminus of Aβ 1-42 mediates Aβ 1-42 -induced toxicity is consistent with findings of two recent studies. Luheshi et al. who used a Drosophila model of AD demonstrated that (a) an A2F substitution in Aβ 1-42 increased its toxicity, and (b) whereas an E22G substitution in Aβ 1-42 dramatically increased its toxicity, a double substitution, E22G/F4D, led to a significantly reduced toxicity. 54 In addition, Jin et al. used Aβ dimers isolated from the cortex of AD patients and showed that they mediate toxicity by directly inducing Tau phosphorylation. They further demonstrated that the monoclonal antibodies that bind to the Nterminal D1, but not the antibody that binds to the C-terminus of Aβ 1-42 , inhibited this Aβ-mediated toxicity. 55 In summary, our present results offer mechanistic insights into processes involved in Aβ 1-42 assembly in the presence of Aβ fragments and provide an insight into the putative mechanism(s) by which the CTFs inhibit toxicity. We identified two structural elements, increased β-strand propensity and increased solvent exposure at the N-terminus of Aβ , that correlated with Aβ 1-42 -induced toxicity ( Table 2 ). This work delineates plausible structuretoxicity relationships amenable to in vitro and in vivo testing and provides structural information of potential importance for drug design.
Methods
The DMD approach DMD is a form of molecular dynamics that utilizes interparticle potentials in a form of a single or a combination of square wells, which simplifies calculations of individual trajectories and makes DMD orders of magnitude faster than molecular dynamics. 56 Here, DMD is combined with a four-bead protein model, in which each amino acid is described by up to four beads (representing the amino N, α-carbon C α , carboxyl C, and β-carbon C β groups). 57, 58 This four-bead protein model is based on geometric properties and the backbone hydrogen bonding introduced by Ding et al. 58 The lengths of bonds and the angular constraints are determined phenomenologically by calculating their distributions using the known folded protein structures of ∼ 7700 proteins from the Protein Data Bank. 58, 59 Effective backbone hydrogen bonds are implemented between the nitrogen atom N i of the i-th amino acid and the carbon atom C j of the j-th amino acid. 58 The absolute value of the potential energy of the backbone hydrogen bond interaction, E HB , represents a unit of energy, and the temperature is given in units of E HB /k B . We implemented the amino-acid-specific interactions due to hydropathy and charge of individual side chains that are critical 21 to distinguish between Aβ 1-40 and Aβ 1-42 folding and assembly pathways. 20, 22, 25 The ab initio DMD approach with a four-bead protein model and implicit solvent used in this study is the same as that used in the previous studies of Aβ folding and assembly [22] [23] [24] [25] and has been described in detail by Urbanc et al. 20 Relative to earlier DMD studies, 22, 23, 32 a present DMD parametrization includes a more accurate estimate of physiological temperature and two times longer simulation time, which was recently shown to best account for the distinct oligomer size distributions of Aβ 1-40 , Aβ 1-42 , and their Arctic mutants. 24, 25 The DMD simulation protocol Keeping the number of Aβ 1-42 molecules fixed (either 16 or 6), we varied the number of Aβ X-Y molecules to obtain a desired Aβ 1-42 /Aβ X-Y concentration ratio. The total molar concentration was kept constant across simulations and equal to the one used in our previous study of oligomer formation of full-length Aβ peptides. 25 Initially, the centers of mass of unstructured monomeric Aβ and Aβ X-Y molecules were arranged in the simulation box into a cubic lattice. Distinct initial configurations for multiple trajectories per each Aβ 1-42 / Aβ X-Y concentration were obtained by performing short, high-temperature DMD simulation runs and saving configurations every 0.1 × 10 6 simulation steps. This protocol resulted in randomly placed and mixed peptides of each type that were used as initial populations for production runs (Fig. I in Supplementary Material) . Multiple trajectories at each Aβ 1-42 /Aβ X-Y concentration ratio were acquired at physiological temperature (T = 0.13) using the implicit solvent parameters E HP = 0.3 and E CH = 0 that best described the initial hydrophobic collapse into globular Aβ 1-42 oligomers. For each of the four Aβ X-Y , five different molar concentration ratios were studied, resulting in 20 systems. For each system, eight trajectories of 20 × 10 6 simulation steps were acquired. The resulting Aβ structures formed in the presence of Aβ X-Y molecules were quantified in terms of their secondary, tertiary, and quaternary structures and solvent exposure and compared to unaltered Aβ 1-42 oligomer structures derived previously. 25 Supplementary Methods in Supplementary Material provides a more detailed description of our computational approach and its limitations. 
Supplementary Methods
Discrete Molecular Dynamics. DMD is a form of MD that can be applied when the interparticle potentials are approximated by one or more square wells [1] . The force between two particles is then non-zero only at discrete distances, at which the particles collide, rendering DMD eventdriven. Between events/collisions, particles move along straight lines with constant speeds, which simplifies calculations of individual trajectories and makes DMD orders of magnitude faster than MD, which is important for studying protein assembly at biologically relevant time scales [2] . In our DMD approach, the simulation volume and number of particles are fixed, the temperature is held constant by the Berendsen thermostat [3] , and periodic boundary conditions are implemented [4] .
The Four-Bead Protein Model with Amino Acid-Specific Interactions. In the four-bead protein model, the backbone is represented by three beads, corresponding to the amide (N), the α-carbon (C α ), and the carbonyl (C) groups. Each side-chain is represented by one side-chain bead (C β ). The aqueous solvent is implemented by introducing effective amino acid-specific hydropathic interactions among C β atoms [5] using the hydropathy scale derived by Kyte and Doolittle [6] . At neutral pH, the amino acids I, V, L, F, C, M, and A are considered hydrophobic, N, Q, and H are considered non-charged hydrophilic, and R, K, D, and E are considered charged hydrophilic. The remaining amino acids with absolute values of hydropathies below threshold values are treated as neutral. Each C β atom is associated with a hydropathy parameter normalized between −1 (for the most hydrophobic residue) to +1 (for the most hydrophilic residue) and neutral C β atoms are assigned a zero hydropathy parameter. Attractive or repulsive C β -C β interactions are implemented within the group of hydrophobic residues or within the group of hydrophilic residues, respectively. The remaining C β -C β interactions are due to the excluded volume effect. The effective hydropathic interaction is modeled by a single square-well potential with the absolute value of the potential energy (or the strength of the interaction) equal to E HP and the interaction range of 0.75 nm. When the C β -C β distance of two hydrophobic/hydrophilic side-chain atoms decreases from above to below 0.75 nm, the two atoms experience an attractive/repulsive interaction, equal to E HP multiplied by an average of their respective hydropathy parameters.
The implicit solvent parameter E HP , which strongly depends on the 4 presence or absence of water in the solvent, is set to E HP = 0.3 (in units of E HB ) [5, 7, 8] . The interaction between two hydrophobic side chains is attractive, to mimic the tendency of each hydrophobic residue to decrease its solvent exposure. The interaction between two hydrophilic side chains is repulsive, to mimic the tendency of the two hydrophilic residues to maximize their total solvent exposure. The effective electrostatic interactions, as discussed in detail in our recent work [8] , are not expected to play a significant role at the early stages of Aβ assembly, thus the corresponding implicit solvent parameter was set to zero, E CH = 0. Under such conditions, the charged amino acids R, K, D, and E are considered purely hydrophilic.
Limitations of the DMD Approach. The present DMD simulations are limited by: (i) the use of high molar concentrations (about 100-fold higher than those used in vitro), resulting in assembly populations that lack Aβ 1−42 monomers; and (ii) the modeling of the early, hydrophobic-collapse stage of the assembly during which effective electrostatic interactions may not play a key role. With regard to the high concentrations used in the simulations, we note that the in vitro oligomer distributions are actually quite insensitive to the concentration for concentrations above a threshold of ∼1-3 µM under which large oligomers, e.g. pentamers and hexamers, begin to fall apart into dimers and trimers (G. Bitan, unpublished data). In contrast, the aggregation kinetics is sensitive to the concentration. The rate at which the oligomers eventually assemble into larger aggregates and fibrils is accelerated as the concentration increases, but the oligomer distribution itself does not change appreciably. Due to these limitations as well as the limited number of peptide chains that can be simulated, our approach is tuned to simulate a single population of Aβ 1−42 /CTF heterooligomers and cannot account for the larger of the two assembly populations observed by DLS [9, 10] . The initial hydrophobic collapse and a much slower aggregation into fibrils occur at two well-separated time scales and likely involve distinct assembly mechanisms. The DMD approach captures oligomer formation and resulting structures but cannot be used, in its current form, to predict the ability of heterotypic assemblies to aggregate into fibrils.
Simulation Parameters.
In prior work, we reported results of preliminary simulations of Aβ 1−42 in the presence of Aβ 29−42 , Aβ 31−42 , or Aβ 39−42 [9] . These preliminary simulations were performed at a temperature of T = 0.15 and the corresponding trajectories were each 10 × 10 6 simulation steps long. Here, new simulation trajectories, each 20 × 10 6 sim-5 ulation steps long, were acquired at a better estimate of the physiological temperature of T = 0.13, which was recently shown to result in a closer agreement between in silico and in vitro findings [11, 8] . In addition, the box sizes (volumes) in the present simulations were adjusted to the Aβ fragment length and the concentration ratio Aβ 1−42 :CTF to keep the total molar concentration 3 approximately the same for all systems under study across all Aβ fragment concentrations and equal to the molar concentration used in our previous work with 32 Aβ 1−42 molecules in a cubic simulation box of size 250Å [5, 7, 8] .
In the first set of simulations reported here, we studied Aβ Table I . Initially, the centers of mass of unstructured monomeric Aβ 1−42 and Aβ fragments were arranged in the simulation box into a cubic lattice. Within the simulation box, Aβ 1−42 and Aβ fragments were segregated with Aβ 1−42 molecules on one side, and Aβ X−Y peptides on the other side ( Fig. Ia) . Distinct initial configurations 5 for 8 trajectories per Aβ fragment per number concentration ratio were obtained by performing short high-temperature (T = 4) DMD simulation runs and saving configurations every 0.1 × 10 6 simulation steps. This protocol resulted in randomly-placed peptides of each of the two types, as expected based on entropy considerations (Fig. Ib) . We conducted eight productions runs per Aβ X−Y per concentration ratio, in total acquiring 128 trajectories, each 20 × 10 6 simulation steps long.
The purpose of the first set of simulations described above was to examine heterotypic assemblies formed by Aβ 1−42 and Aβ X−Y and quantify the changes in structural properties of Aβ 1−42 with increasing relative concentration of Aβ fragments. The relative molar concentrations of Aβ X−Y explored in the first set of simulations (Table I) were low relative to the Aβ 1−42 :CTF molar concentration ∼1:10, which was required to inhibit Aβ 1−42 toxicity in cell cultures [9] . To delve into structural characteristics of heterooligomers at the molar concentration ratios relevant to toxicity inhibition, we acquired a second set of simulations of 6 Aβ 1−42 assembling in the presence of (a) 229 Aβ 30−40 , (b) 210 Aβ 31−42 , (c) 630 Aβ 39−42 , and (d) 252 Aβ 21−30 molecules. The simulation box in all three cases was selected to match the overall molar concentration in the first set of simulations, 318Å. The total molar concentration used was 10-100 fold larger than in typical in vitro conditions. Such a high molar concentration is needed to increase the probability of intermolecular interactions, making the assembly process fast enough to be observed and quantified in silico. In this second set of simulations, we acquired for each of the four Aβ fragments 8 trajectories of 20 × 10 6 simulation steps, in total 32 trajectories, following the same protocol, temperature, and implicit solvent parameters as in the first set of simulations.
Structural Analysis.
Probability Distributions of Assembly Sizes. The acquired DMD trajectories contained populations of Aβ 1−42 and Aβ X−Y monomers, Aβ 1−42 and Aβ X−Y oligomers, and heterotypic assemblies comprising both Aβ 1−42 and Aβ X−Y peptides. To identify the connections between individual chains within each assembly we used the criterion that was introduced in the previous studies [5, 7, 8] , in which two chains A and B are considered to be part of the same assembly if there exists a pair of atoms, one from chain A and one from chain B, such that the distance between the center of masses of the two atoms is less than 0.75 nm.
In total, eight trajectories of Aβ 1−42 assembly in the presence of Aβ fragments were produced for each Aβ X−Y and each Aβ 1−42 :Aβ X−Y concen-7 tration ratio. The size distributions of resulting assemblies were calculated by taking into account populations of assemblies at time frames of 19, 19.5, and 20×10 6 simulation steps to facilitate comparison to the Aβ 1−42 oligomer size distribution obtained in the absence of Aβ fragments in our previous work [8] . For each of these 24 assembly populations, the probability distributions of Aβ 1−42 and Aβ X−Y assemblies of all sizes within the heterotypic assemblies were calculated. This was achieved by considering the spatial coordinates of either only Aβ 1−42 peptides or only Aβ X−Y peptides and applying the above criterion to determine whether two peptide chains, belonged to the same assembly. The final normalized probability size distributions of Aβ 1−42 and Aβ X−Y assemblies within the Aβ 1−42 /Aβ X−Y heterooligomers and the standard errors of the mean (SEM) were calculated as averages over 24 individual probability distributions.
Contact Maps. For contact map analysis and all the other analyses described below, realizations at eleven time frames between 19 and 20 × 10 6 simulation steps (at 10 5 -step intervals) were considered. A contact map is a matrix in which the value of each (i,j) element is equal to an average number of contacts between amino acids i and j. We consider two types of contact maps: intra-and intermolecular contact maps. If amino acids i and j belong to the same peptide, the corresponding contacts contribute to the intramolecular contact map, otherwise, to the intermolecular contact map. For a mixture of heterotypic assemblies, we calculate two intra-and three intermolecular contact maps, including the "cross" intermolecular contact map. The contact map of each assembly is normalized by the number of contributing peptide molecules. We normalize intermolecular contact maps between Aβ 1−42 and Aβ X−Y molecules by the number of Aβ 1−42 molecules so that the average strength of a contact at (i,j) corresponds to the average number of contacts between amino acid i belonging to Aβ 1−42 and amino acid j belonging to Aβ X−Y . In the four-bead protein model each amino acid is represented by up to four beads, thus the maximal number of intramolecular contacts between residues i and j is 4×4=16. The maximal number of intermolecular contacts between residues i and j can be larger than 16 because amino acid i of one molecule can be surrounded by several amino acids j from multiple molecules. We represent the final average contact maps on a color scale between 0 (dark blue) and 1 (pink), where 0 means no significant contacts and 1 corresponds to 16 contacts, i.e. to one full contact between two amino acids. All colors other than dark blue denote significant non-zero contacts between amino acids, for which the average 8 number of contacts is larger than the corresponding SEM.
Binding Propensity. To quantify the degree of intermolecular interactions between each Aβ fragment and Aβ 1−42 , we calculated a binding propensity, defined as an average contact strength, i.e., the average number of contacts between two specified regions of the peptides in contact. Binding propensity as defined here is a dimensionless quantity, normalized in the same way as the contact maps, with the value of 1 corresponding to one full contact between two amino acids. Its value can be larger than 1 because any amino acid belonging to Aβ 1−42 can be in contact with the another amino acid involving multiple Aβ X−Y peptides.
Secondary Structure.
Amino acid-specific propensities for the secondary structure formation were calculated using the STRIDE program [12, 13] . The secondary structure propensities included several types of αhelical, β-strand, turn, and bridge structures. Here we analyzed in detail the dominant secondary structure element, the β-strand.
Solvent Accessible Surface Area. We calculated the solvent accessible surface area per amino acid (SASA) by using the Visual Molecular Dynamics (VMD) software package [14] . This calculation uses a spherical surface around each of the four beads (three in the case of glycine), 1.4Å away from the atom's van der Waals surface. The joint "free" surface area for all atoms in an amino acid is then calculated by taking into account surfaces of all other atoms in the assembly. We also consider the backbone carbonyl oxygen and amide hydrogen involved in the hydrogen bond formation. The "free" surface area is defined as the area free of contact with other atoms, which would thus be exposed to the solvent. Amino acids that are buried inside an assembly have small SASA values, whereas amino acids on the surface assume high SASA values.
at four different Aβ 1−42 :Aβ X−Y concentration ratios, to elucidate the spatial distribution of the two molecule types within the heterotypic assemblies. The size distributions of Aβ 1−42 versus Aβ X−Y assemblies were examined to elucidate the preference of Aβ 1−42 (or Aβ X−Y ) to either self-assemble of associate with Aβ X−Y (or Aβ 1−42 ). Our results showed that Aβ 1−42 and Aβ X−Y size distributions strongly depended on the Aβ 1−42 :Aβ X−Y concentration ratio.
At low Aβ X−Y concentrations that corresponded to molar concentration ratios 1:MC with MC < 1 (Table I) , the three toxicity inhibitors promoted Aβ 1−42 assembly by enhancing self-association of Aβ 1−42 molecules that resulted in large connected Aβ 1−42 structures as demonstrated by a dominant peak at n = 16 in the corresponding probability distributions (Fig. IIa-c , orange and green curves). At these same concentration ratios, the CTF molecules within heterooligomers formed connected structures of characteristic sizes that depended on the CTF type ( Fig. IIe-g , orange and green curves). At the two lowest CTF concentrations, the characteristic sizes of the connected CTF structure were:
Aβ 30−40 : n = 4 (P = 0.31 for 1:1), n = 8 (P = 0.15 for 1:1 and P = 0.20 for 1:2) and n = 24 (P = 0.20 for 1:2);
Aβ 31−42 : n = 2 (P = 0.28 for 1:1), n = 5 (P = 0.13 for 1:1), n = 12 (P = 0.13 for 1:1 and P = 0.19 for 1:2) and n = 20 (P = 0.17 for 1:2); Aβ 39−42 : n = 3 (P = 0.21 for 1:2) and n = 8 (P = 0.14 for 1:4), where 1:1, 1:2, and 1:4 refer to the Aβ 1−42 :CTF number concentration ratio and P is the probability of occurrence. Only the low molecular weight (n ≤ 24) structures with P > 0.1 were considered. Interestingly, Aβ 30−40 self-assembled into tetramers and octamers, Aβ 31−42 into dimers, pentamers, and dodecamers (resembling the oligomer size distribution of Aβ 1−42 ), and Aβ 39−42 into trimers and octamers. Thus, at low CTF concentrations each of the three types of CTFs were characterized by a particular pattern of self-assembly and the characteristic Aβ 30−40 and Aβ 39−42 assemblies were more similar to each other than to Aβ 31−42 .
At CTF concentrations that corresponded to relative molar concentrations larger than 1:2 (see Table I ), CTF molecules were numerous enough to insert themselves in-between Aβ 1−42 molecules and consequently break the large connected Aβ 1−42 structures into smaller ones, resulting in a significant decrease of the peak at n = 16 and increased probabilities at small Aβ 1−42 assembly sizes ( Fig. IIa-c, blue and magenta curves) . Interestingly, at Aβ 1−42 :Aβ 30−40 number concentration ratio 1:4, the peak at n = 16 was replaced by a peak at n = 2 and another peak at n = 16 − 2 = 14, suggesting that Aβ 30−40 caused dissociation of larger Aβ 1−42 oligomers into Aβ 1−42 dimers (Fig. IIa, the blue curve) . A similar tendency was observed for Aβ 39−42 (Fig. IIc, the blue curve) but not for Aβ 31−42 (Fig. IIb, the blue  curve) . At the Aβ 1−42 :Aβ 31−42 number concentration ratio 1:4, a peak at monomers (n = 1) and another peak at n = 16 − 1 = 15 suggested that Aβ The control Aβ fragment that was previously shown not to affect Aβ 1−42 toxicity in cell cultures, Aβ 21−30 , had quite a different effect on Aβ 1−42 assembly (Fig. IId,h) . In a concentration-dependent way, Aβ 21−30 efficiently inhibited Aβ 1−42 assembly, such that at the 1:8 number concentration ratio, ∼90% of Aβ 1−42 peptides were spatially separated from each other. Interestingly, increased Aβ 21−30 concentration promoted the association of Aβ 1−42 into small heterotypic Aβ 1−42 /Aβ 21−30 assemblies. Among these, a typical heterooligomer comprised one Aβ 1−42 molecule associated with 7 to 8 Aβ 21−30 peptides ( Fig. 2e ).
Effect of Aβ Fragment Concentration on Aβ 1−42 Tertiary Structure.
As demonstrated in our recent work [8] , the tertiary structure within Aβ 1−42 hexamers formed in the absence of Aβ fragments included four turn regions, of which the central folding region centered at G25- S26 11 was associated with the largest number of strong contacts, followed by the turn region centered at G37-G38 ( Fig. IIIa, boxes 3,4 ). Additional two turns were centered at S8-G9 and Q15-K16 (Fig. IIIa, boxes 1,2) . These turns were flanked by regions of increased β-strand propensity, resulting in bands of contacts perpendicular to the main diagonal ( Fig. IIIa, boxes 1-4) .
The regions most involved in intramolecular contacts were the CHC, MHR, and CTR. In the absence of CTFs, Aβ 1−42 but not Aβ 1−40 monomers were characterized by a turn centered at G37-G38 [5] , and the CTR of Aβ 1−42 oligomers was involved in significantly more and stronger contacts than the CTR of Aβ 1−40 , resulting in the group of intramolecular contacts between the CHC and MHR/CTR [8] (Fig. IIIa, box 5 ).
In the presence of all Aβ fragments, the Aβ 1−42 tertiary structure preserved all characteristic turn regions ( Fig. IIIb-r) , even though the strength of the strongest contacts decreased relative to pure Aβ 1−42 hexamers in a concentration-dependent manner. Simultaneously, we observed that the presence of the the three toxicity inhibitors resulted in minor spreading of the "native" tertiary Aβ 1−42 contacts onto the neighboring amino acids, similar to a conformational change from the native to the molten globule state observed during denaturation [15] . This conformational change in the Aβ 1−42 tertiary structure was consistent with the reduced β-strand propensity observed in the presence of toxicity inhibitors (Fig. 3a , black, red and green solid curves). In contrast, the control peptide Aβ 21−30 increased the strengths of tertiary contacts involving the CHC, MHR, and CTR and thus stabilized the Aβ 1−42 tertiary fold while simultaneously increasing its β-strand propensity (Fig. 3a, grey curve) .
The presence of the three toxicity inhibitors, almost independently of their concentration, reduced the number and strengths of intramolecular contacts in the central folding region of Aβ 1−42 ( Fig. IIIb-d ,f-h,j-l,n-p, box 3), which was hypothesized to nucleate Aβ folding [16] . The control peptide Aβ 21−30 , in contrast, increased the strengths of intramolecular Aβ 1−42 contacts in the central folding region relative to Aβ 1−42 hexamers formed in the absence of fragments (Fig. IIIe,i,m,r, box 3) . The three toxicity inhibitors also reduced the intramolecular contacts between the CHC and MHR as well as the CHC and CTR ( Fig. IIIb-d ,f-h,j-l,n-p, box 5), whereas the control peptide had the reverse effect ( Fig. IIIe,i ,m,r, box 5). Again, for all Aβ fragments, the effect was concentration dependent. The reduction of intramolecular contacts in this region was most pronounced for Aβ 39−42 (Fig. IIIp, box 5 ). Of the four Aβ fragments, only the highest concentra-tion of Aβ 30−40 slightly reduced the number of contacts centered at S8-G9 ( Fig. IIIn, box 1) , whereas the other three fragments did not significantly affect this region even at the highest concentrations ( Fig. IIIo-r, box 1) .
Effect of Aβ X−Y Fragment Concentration on Aβ 1−42 Quaternary Structure.
The quaternary structure of Aβ 1−42 hexamers formed in the absence of Aβ fragments was characterized by several intermolecular contact regions [8] (Fig. IVa, boxes 1-4) . The strongest contacts were among the CTRs and between the CTR and MHR (Fig. IVa, box 4) , between the CHC and MHR/CTR (Fig. IVa, box 3) , and among the CHC regions ( Fig. IVa, box 2) . The intermolecular contacts in Aβ 1−42 oligomers were dominated by the CTR, as opposed to the predominant role of the CHC in Aβ 1−40 oligomers [7] . Relative to the quaternary structure of these pure Aβ 1−42 hexamers, (Fig. IVa) , the Aβ 1−42 intermolecular contacts were drastically reduced in strengths within the Aβ 1−42 /Aβ X−Y heterotypic assemblies in an Aβ fragment concentration-dependent manner (Fig. IVbr) . The quaternary structure of Aβ 1−42 molecules in heterotypic assemblies was significantly affected even at the lowest Aβ fragment concentrations ( Fig. IVb,c,d,e ). In the presence of the three toxicity inhibitors, but not the control peptide Aβ 21−30 , the intermolecular contacts were reduced in strength and were spread to the neighboring amino acids, akin to denaturation-induced changes from native to molten globule contacts. Interestingly, at low Aβ 1−42 :Aβ X−Y number concentration ratios, the intermolecular contacts among N-terminal regions, A2-F4, became stronger in the presence of the three CTFs but not in the presence of Aβ 21−30 (Fig. IVb,c,d,e ) relative to those in pure Aβ 1−42 hexamers (Fig. IVa) . We recently identified parallel, in-register intermolecular contacts involving the A2-F4 regions as a characteristic feature of Aβ 1−40 but not of Aβ 1−42 hexamers [8] . In the presence of Aβ 39−42 , additional antiparallel intermolecular contacts among the A2-Y10 regions were observed, suggesting that the presence of Aβ 39−42 resulted in increased heterogeneity of Aβ 1−42 association (Fig. IVd) .
The reduction of Aβ 1−42 intermolecular contacts in the presence of the control peptide Aβ 21−30 was not surprising as the assembly size distributions demonstrated that the presence of Aβ 21−30 stabilized Aβ 1−42 monomers. Why was there a concentration-dependent decrease in Aβ 1−42 intermolecular contacts in the presence of the three toxicity inhibitors, which promoted Aβ 1−42 co-assembly with CTFs? The first reason for this decrease was the insertion of CTF molecules in-between the Aβ 1−42 molecules, which resulted in diminished contacts among Aβ 1−42 peptides within heterooligomers. This interpretation was consistent with Aβ 1−42 assembly size distributions (Fig. IIac) , which evolved from a single peak at n = 16 at the lowest CTF concentration to an increased number of Aβ 1−42 monomers and small assemblies (n < 16) at higher CTF concentrations. However, the displacement of Aβ 1−42 molecules within heterooligomers themselves was not sufficient to explain an almost complete absence of intermolecular contacts at the highest Aβ 30−40 concentration (Fig. IVn) because at that concentration the Aβ 1−42 assembly size distribution still showed considerable numbers of Aβ 1−42 assemblies of orders n = 2, 3, 4, 8, which should have contributed to intermolecular contacts. The second reason for the absence of Aβ 1−42 intermolecular contacts in the presence of a large concentration of Aβ 30−40 was the loss of well-defined contact regions among Aβ 1−42 molecules induced and mediated by Aβ 30−40 . The lack of specified intermolecular contact regions among Aβ 1−42 due to Aβ 30−40 -mediated disorder in Aβ 1−42 association resulted in an averaged-out contact map and was consistent with the reduction in the β-strand propensity in Aβ 1−42 within Aβ 1−42 /Aβ 30−40 heterooligomers. Aβ 1−42 assemblies within heterooligomers thus were more diverse both in terms of the specificity of interacting regions within a single heterooligomer and among different heterooligomers. We concluded that Aβ 1−42 assemblies within heterooligomers had a more disordered structure than Aβ 1−42 oligomers formed in the absence of CTFs.
A decrease in the number and strengths of Aβ 1−42 intermolecular contacts, though not as pronounced as in the case of Aβ 30−40 , was observed also at the highest concentration of Aβ 31−42 (Fig. IVo) . The Aβ 1−42 intermolecular contacts among the CTRs, between the CTR and MHR (Fig. IVo, box  4) , and between the CTR and CHC (Fig. IVo, box 3) were still present, though at reduced numbers and weaker strengths relative to pure Aβ 1−42 hexamers. Even though Aβ 30−40 and Aβ 31−42 showed similar ability to displace Aβ 1−42 molecules, as demonstrated by the size distributions of Aβ 1−42 assemblies (Fig. IIa,c) , the intermolecular contact maps suggested that the contact regions among Aβ 1−42 molecules within Aβ 1−42 /Aβ 31−42 heterooligomers were better defined (more closely resembling the contacts characteristic for Aβ 1−42 hexamers formed in the absence of fragments) than within Aβ 1−42 /Aβ 30−40 heterooligomers. In addition, we observed new Aβ 1−42 intermolecular contacts (not existing in the pure Aβ 1−42 hexamers) corresponding to an antiparallel structure involving E11-L17 in Aβ 1−42 /Aβ 31−42 heterooligomers (Fig. IVo, box 5) .
The highest concentration of Aβ 39−42 , similar to the highest concentra- 
